DCGI nod to Phase-1 human trials of 'antisera' with potential to treat COVID-19

Antisera are blood serum high in antibodies against specific antigens and are injected in humans to help kickstart the immune system to fight specific infections.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news